Cite
HARVARD Citation
Liu, M. et al. (2022). The efficacy and toxicity of maintenance therapy with bevacizumab plus pemetrexed versus bevacizumab/pemetrexed alone for stage IIIB/IV nonsquamous non‐small cell lung cancer: A meta‐analysis of randomized controlled trials. Journal of clinical pharmacy and therapeutics. pp. 157-167. [Online].